The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
finafloxacin · FINAFLOXACIN 3 mg/mL · Suspension · Auricular (Otic) · Fonseca Biosciences, LLC
NDC 83709-0001-01 · 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER · NDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
| Type | Number / code | Expires |
|---|---|---|
| patent | 9504691 | Nov 21, 2033 |
| patent | 8536167 | Aug 8, 2031 |
| patent | 9119859 | Jul 2, 2030 |
| patent | 9993483 | Jul 2, 2030 |
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fonseca Biosciences, LLC | FINAFLOXACIN 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Xtoro — NDC 83709-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/83709000101.
Free to cite with attribution — see how the data is put together.